Predicting survival times for neuroblastoma patients using RNA-seq expression profiles

BACKGROUND: Neuroblastoma is the most common tumor of early childhood and is notorious for its high variability in clinical presentation. Accurate prognosis has remained a challenge for many patients. In this study, expression profiles from RNA-sequencing are used to predict survival times directly....

Descripción completa

Detalles Bibliográficos
Autores principales: Grimes, Tyler, Walker, Alejandro R., Datta, Susmita, Datta, Somnath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977759/
https://www.ncbi.nlm.nih.gov/pubmed/29848365
http://dx.doi.org/10.1186/s13062-018-0213-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977759/
https://www.ncbi.nlm.nih.gov/pubmed/29848365
http://dx.doi.org/10.1186/s13062-018-0213-x

Ejemplares similares